193 related articles for article (PubMed ID: 10191110)
1. Reevaluation of neuronal ceroid lipofuscinoses: atypical juvenile onset may be the result of CLN2 mutations.
Wisniewski KE; Kaczmarski A; Kida E; Connell F; Kaczmarski W; Michalewski MP; Moroziewicz DN; Zhong N
Mol Genet Metab; 1999 Apr; 66(4):248-52. PubMed ID: 10191110
[TBL] [Abstract][Full Text] [Related]
2. Neuronal ceroid lipofuscinoses: research update.
Wisniewski KE; Kida E; Connell F; Zhong N
Neurol Sci; 2000; 21(3 Suppl):S49-56. PubMed ID: 11073228
[TBL] [Abstract][Full Text] [Related]
3. Strategy for mutation detection in CLN3: characterisation of two Finnish mutations.
Munroe PB; O'Rawe AM; Mitchison HM; Järvelä IE; Santavuori P; Lerner TJ; Taschner PE; Gardiner RM; Mole SE
Neuropediatrics; 1997 Feb; 28(1):15-7. PubMed ID: 9151312
[TBL] [Abstract][Full Text] [Related]
4. Genetic linkage analysis of a variant of juvenile onset neuronal ceroid lipofuscinosis with granular osmiophilic deposits.
O'Rawe A; Mitchison HM; Williams R; Wheeler R; Andermann E; Andermann F; Hart YM; Martin JJ; Philippart M; Stephenson JB; Gardiner RM; Mole SE
Neuropediatrics; 1997 Feb; 28(1):21-2. PubMed ID: 9151314
[TBL] [Abstract][Full Text] [Related]
5. Genotype-phenotype correlations in neuronal ceroid lipofuscinosis due to palmitoyl-protein thioesterase deficiency.
Hofmann SL; Das AK; Yi W; Lu JY; Wisniewski KE
Mol Genet Metab; 1999 Apr; 66(4):234-9. PubMed ID: 10191107
[TBL] [Abstract][Full Text] [Related]
6. Late infantile neuronal ceroid lipofuscinosis: a new mutation in Arabs.
Goldberg-Stern H; Halevi A; Marom D; Straussberg R; Mimouni-Bloch A
Pediatr Neurol; 2009 Oct; 41(4):297-300. PubMed ID: 19748052
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5.
Mole SE; Mitchison HM; Munroe PB
Hum Mutat; 1999; 14(3):199-215. PubMed ID: 10477428
[TBL] [Abstract][Full Text] [Related]
8. Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X).
Sarpong A; Schottmann G; Rüther K; Stoltenburg G; Kohlschütter A; Hübner C; Schuelke M
Clin Genet; 2009 Jul; 76(1):38-45. PubMed ID: 19489875
[TBL] [Abstract][Full Text] [Related]
9. Tissue expression and subcellular localization of CLN3, the Batten disease protein.
Margraf LR; Boriack RL; Routheut AA; Cuppen I; Alhilali L; Bennett CJ; Bennett MJ
Mol Genet Metab; 1999 Apr; 66(4):283-9. PubMed ID: 10191116
[TBL] [Abstract][Full Text] [Related]
10. Identification of three novel mutations of the palmitoyl-protein thioesterase-1 (PPT1) gene in children with neuronal ceroid-lipofuscinosis.
Waliany S; Das AK; Gaben A; Wisniewski KE; Hofmann SL
Hum Mutat; 2000 Feb; 15(2):206-7. PubMed ID: 10649502
[TBL] [Abstract][Full Text] [Related]
11. A CLN5 mutation causing an atypical neuronal ceroid lipofuscinosis of juvenile onset.
Pineda-Trujillo N; Cornejo W; Carrizosa J; Wheeler RB; Múnera S; Valencia A; Agudelo-Arango J; Cogollo A; Anderson G; Bedoya G; Mole SE; Ruíz-Linares A
Neurology; 2005 Feb; 64(4):740-2. PubMed ID: 15728307
[TBL] [Abstract][Full Text] [Related]
12. Late onset juvenile neuronal ceroid-lipofuscinosis with granular osmiophilic deposits (GROD).
Hofman IL; Taschner PE
Am J Med Genet; 1995 Jun; 57(2):165-7. PubMed ID: 7668323
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight storage material in infantile ceroid lipofuscinosis (CLN1).
Dawson G; Cho S; Siakotos AN; Kilkus J
Neuropediatrics; 1997 Feb; 28(1):31-2. PubMed ID: 9151317
[TBL] [Abstract][Full Text] [Related]
14. Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotype.
Kwon JM; Rothberg PG; Leman AR; Weimer JM; Mink JW; Pearce DA
Neurosci Lett; 2005 Oct; 387(2):111-4. PubMed ID: 16087292
[TBL] [Abstract][Full Text] [Related]
15. A variant form of late infantile neuronal ceroid lipofuscinosis (CLN5) is not an allelic form of Batten (Spielmeyer-Vogt-Sjögren, CLN3) disease: exclusion of linkage to the CLN3 region of chromosome 16.
Williams R; Santavuori P; Peltonen L; Gardiner RM; Järvelä I
Genomics; 1994 Mar; 20(2):289-90. PubMed ID: 8020979
[TBL] [Abstract][Full Text] [Related]
16. The clinical and genetic epidemiology of neuronal ceroid lipofuscinosis in Newfoundland.
Moore SJ; Buckley DJ; MacMillan A; Marshall HD; Steele L; Ray PN; Nawaz Z; Baskin B; Frecker M; Carr SM; Ives E; Parfrey PS
Clin Genet; 2008 Sep; 74(3):213-22. PubMed ID: 18684116
[TBL] [Abstract][Full Text] [Related]
17. Structure of the CLN3 gene and predicted structure, location and function of CLN3 protein.
Mitchison HM; Taschner PE; Kremmidiotis G; Callen DF; Doggett NA; Lerner TJ; Janes RB; Wallace BA; Munroe PB; O'Rawe AM; Gardiner RM; Mole SE
Neuropediatrics; 1997 Feb; 28(1):12-4. PubMed ID: 9151311
[TBL] [Abstract][Full Text] [Related]
18. Neural and extraneural expression of the neuronal ceroid lipofuscinoses genes CLN1, CLN2, and CLN3: functional implications for CLN3.
Chattopadhyay S; Pearce DA
Mol Genet Metab; 2000; 71(1-2):207-11. PubMed ID: 11001812
[TBL] [Abstract][Full Text] [Related]
19. The molecular basis of GROD-storing neuronal ceroid lipofuscinoses in Scotland.
Stephenson JB; Greene ND; Leung KY; Munroe PB; Mole SE; Gardiner RM; Taschner PE; O'Regan M; Naismith K; Crow YJ; Mitchison HM
Mol Genet Metab; 1999 Apr; 66(4):245-7. PubMed ID: 10191109
[TBL] [Abstract][Full Text] [Related]
20. Genotype-phenotype analyses of classic neuronal ceroid lipofuscinosis (NCLs): genetic predictions from clinical and pathological findings.
Ju W; Wronska A; Moroziewicz DN; Zhong R; Wisniewski N; Jurkiewicz A; Fiory M; Wisniewski KE; Johnston L; Brown WT; Zhong N
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 38(1):41-8. PubMed ID: 16415965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
